<DOC>
	<DOCNO>NCT02094638</DOCNO>
	<brief_summary>Tanreqing Injection widely use respiratory disease Chinese medicine syndrome retention phlegm heat Fei . This study record clinical use Tanreqing Injection real world , observe adverse drug reactions/ adverse drug event treatment , figure Tanreqing induce severe allergic reaction happens .</brief_summary>
	<brief_title>Post-Marketing Surveillance Tanreqing Injection : Real World Study</brief_title>
	<detailed_description>As compound traditional Chinese medicine , Tanreqing Injection approve China Food Drug Administration ( CFDA ) 2003 , widely use respiratory disease , biofilm relate upper respiratory infection , pneumonia bronchitis . During 11 year market China , hardly serious adverse drug reaction except case report severe allergic reaction . In study , clinical pharmacist select hospital record clinical use adverse drug reactions/ adverse drug event injection , also try figure drug-induced severe allergic reaction happen nest case-control study . This real world study Tanreqing Injection 30400 patient conduct January.2014 June.2016 .</detailed_description>
	<mesh_term>Drug-Related Side Effects Adverse Reactions</mesh_term>
	<mesh_term>Drug Hypersensitivity</mesh_term>
	<criteria>Patients use Tanreqing Injection select hospital China , include inpatient outpatient . Outpatients hospital get patient ' complete information . Patients less 24 month .</criteria>
	<gender>All</gender>
	<minimum_age>24 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Traditional Chinese Medicine Injection</keyword>
</DOC>